Publication | Closed Access

Anticancer activity for 4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and Their abilities to interact with lymphoendothelial cell surface markers

Medicinal ChemistryDrug TargetingMedicineCancer Cell BiologyAnticancer ActivityTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryTumor BiologyDrug Discovery